EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Recent Searches
Trending
-
How do you steady the course of your IPO journey in a changing landscape?
27 Mar 2024 Private business IPO Start-ups Entrepreneurship Assurance Audit Family enterprise Technology Power and utilities Oil and gas Banking transformation Life sciences Health Private equity -
How can the moments that threaten your transformation define its success?
15 Apr 2024 Consulting Transformation Realized Workforce -
Artificial Intelligence
16 Nov 2023 AI
Select your location
Local sites
How Life Sciences 4.0 is fusing the digital and biological worlds
At EY, we’re committed to creating a better working world and also a much healthier one.
Health is being reimagined in ways that fuse the digital, physical and biological worlds. Increased customer expectations and rapid technological advances are reshaping the health care industry.
Newly empowered super consumers are driving this change, calling for more engaging, connected care. As demands for proactive, personalized health increase, data-driven algorithms that improve outcomes will become the most valuable health care products. Reimagining this reality requires a new, shared approach. One of collaboration and convergence – what we call Life Sciences 4.0.
Watch this illustrative short film to see how collecting, combining and sharing data can drive innovation and better health outcomes. When the human body is the biggest data platform, how will you capture value?
Summary
The way we think about health care is changing. New technologies are enabling the industry to reorganize itself around patients, who, equipped with better information, will take more control of their own care.
